published in accordance with the WHO format and distributed to all public hospitals and same would be made available in all private hospitals and pharmacies for implementation; (d) the new Technical Committee would collate and capture data on the VigiFlow ® and the Vigibase® database of the Uppsala Monitoring Centre for analysis based on established standards; (e) in order to encourage reporting of Adverse Drug Reactions, the Ministry of Health and Wellness would carry out sensitisation